Annual Changes to the NASDAQ Biotechnology Index
NEW YORK, Dec. 14, 2015 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq:NDAQ) today announced the results of the annual re-ranking of the NASDAQ Biotechnology Index (Nasdaq:NBI), which will become effective prior to market open on Monday, December 21, 2015.
The following 60 securities will be added to the Index:
| EXCHANGE | SYMBOL | COMPANY NAME |
| Nasdaq | ADHD | Alcobra Ltd. |
| Nasdaq | ADMS | Adamas Pharmaceuticals, Inc |
| Nasdaq | ADRO | Aduro Biotech, Inc. |
| Nasdaq | AFMD | Affimed N.V. |
| Nasdaq | AGTC | Applied Genetic Technologies |
| Nasdaq | AMRN | Amarin Corporation PLC |
| Nasdaq | ANTH | Anthera Pharmaceuticals, Inc. |
| Nasdaq | AQXP | Aquinox Pharmaceuticals, Inc. |
| Nasdaq | ARDX | Ardelyx, Inc. |
| Nasdaq | ARWR | Arrowhead Research Corp |
| Nasdaq | ATRA | Atara Biotherapeutics |
| Nasdaq | BLCM | Bellicum Pharmaceuticals |
| Nasdaq | BPMC | Blueprint Medicines Corp |
| Nasdaq | CBPO | China Biologic Products, Inc. |
| Nasdaq | CHMA | Chiasma, Inc. |
| Nasdaq | CHRS | Coherus BioSciences, Inc |
| Nasdaq | COLL | Collegium Pharmaceutical |
| Nasdaq | CRIS | Curis Inc |
| Nasdaq | CXRX | Concordia Healthcare |
| Nasdaq | DBVT | DBV Technologies S.A. |
| Nasdaq | DERM | Dermira, Inc. |
| Nasdaq | DNAI | ProNAi Therapeutics, Inc. |
| Nasdaq | DRNA | Dicerna Pharmaceuticals Inc |
| Nasdaq | DRRX | DURECT Corporation |
| Nasdaq | EGLT | Egalet Corporation |
| Nasdaq | EGRX | Eagle Pharmaceuticals, Inc. |
| Nasdaq | ESPR | Esperion Therapeutics |
| Nasdaq | FGEN | FibroGen, Inc. |
| Nasdaq | FLKS | Flex Pharma, Inc. |
| Nasdaq | FLXN | Flexion Therapeutics, Inc. |
| Nasdaq | FOMX | Foamix Pharmaceuticals |
| Nasdaq | IMDZ | Immune Design Corp |
| Nasdaq | INCR | INC Research Hldg |
| Nasdaq | ITEK | Inotek Pharmaceuticals |
| Nasdaq | JUNO | Juno Therapeutics, Inc. |
| Nasdaq | KMPH | KemPharm, Inc. |
| Nasdaq | LBIO | Lion Biotech Inc |
| Nasdaq | LIFE | aTyr Pharma, Inc. |
| Nasdaq | MCRB | Seres Therapeutics |
| Nasdaq | NDRM | NeuroDerm Ltd. |
| Nasdaq | NEOS | Neos Therapeutics, Inc. |
| Nasdaq | NK | NantKwest, Inc. |
| Nasdaq | NSTG | NanoString Technologies |
| Nasdaq | OCUL | Ocular Therapeutix, Inc. |
| Nasdaq | ONCE | Spark Therapeutics, Inc. |
| Nasdaq | ONTY | Oncothyreon Inc. |
| Nasdaq | OTIC | Otonomy, Inc. |
| Nasdaq | OVAS | OvaScience, Inc. |
| Nasdaq | PRAH | PRA Health Sciences, Inc. |
| Nasdaq | QURE | uniQure NV |
| Nasdaq | RIGL | Rigel Pharmaceuticals Inc |
| Nasdaq | TKAI | Tokai Pharmaceuticals |
| Nasdaq | TLGT | Teligent, Inc. |
| Nasdaq | TRVN | Trevena, Inc. |
| Nasdaq | TSRO | TESARO, Inc. |
| Nasdaq | VTAE | Vitae Pharmaceuticals St |
| Nasdaq | VTL | Vital Therapies, Inc. |
| Nasdaq | XBIT | XBiotech Inc. |
| Nasdaq | XNCR | Xencor, Inc. |
| Nasdaq | ZGNX | Zogenix, Inc. |
The Index is designed to track the performance of a set of securities listed on The Nasdaq Stock Market® (NASDAQ®) that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark (ICB).
As a result of the re-ranking, the following twelve securities will be removed from the Index:
| EXCHANGE | SYMBOL | COMPANY NAME |
| Nasdaq | ACRX | AcelRx Pharmaceuticals, Inc. |
| Nasdaq | ALIM | Alimera Sciences Inc |
| Nasdaq | CLDN | Celladon Corporation |
| Nasdaq | DYAX | Dyax Corp. |
| Nasdaq | POZN | POZEN Inc. |
| Nasdaq | PTX | Pernix Therapeutics Hldgs |
| Nasdaq | QLTI | QLT Inc. |
| Nasdaq | SNTA | Synta Pharmaceuticals Corp. |
| Nasdaq | SVA | Sinovac Biotech, Ltd |
| Nasdaq | VSTM | Verastem, Inc. |
| Nasdaq | VVUS | Vivus, Inc. |
| Nasdaq | XOMA | XOMA Corporation |
About Nasdaq Global Indexes
Nasdaq Global Indexes has been creating innovative, market-leading, transparent indexes since 1971. Today, our index offering spans geographies and asset classes and includes diverse families such as the Dividend Achievers, Global, Nordic, Green Economy, Sharia and Commodity Indexes. We continuously offer new opportunities for financial product sponsors across a wide-spectrum of investable products and for asset managers to measure risk and performance. Nasdaq Global Indexes also provides custom index services and design solutions to selected financial organizations. For more information about Nasdaq Global Indexes, visit www.nasdaq.com/indexes.
Daily index values, weightings and historical data for Nasdaq indexes are available via Nasdaq Global Index Watch and Nasdaq Global Index Data Service.
About Nasdaq
Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,600 listed companies with a market value of approximately $8.8 trillion and more than 10,000 corporate clients. To learn more, visit: nasdaq.com/ambition or business.nasdaq.com.
The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular financial product or an overall investment strategy. Neither The NASDAQ OMX Group, Inc. nor any of its affiliates makes any recommendation to buy or sell any financial product or any representation about the financial condition of any company or fund. Statements regarding Nasdaq’s proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.
NDAQG
Media Contacts: Peter Gau, Nasdaq +1.212.231.5475 Will Briganti, Nasdaq +1.646.441.5012 Issuer & Investor Contact: Natasha Selzer, Nasdaq +1.301.978.8623
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
